🎉 M&A multiples are live!
Check it out!

Azenta Valuation Multiples

Discover revenue and EBITDA valuation multiples for Azenta and similar public comparables like Sonic Healthcare, Integral Diagnostics, and ALS.

Azenta Overview

About Azenta

Azenta Inc provides biological and chemical sample exploration and management solutions, using precision automation and cryogenics to develop automated ultra-cold storage. It serves customers from research to commercialization with sample management, automated storage, genomic services, consumables, informatics, and repository services. The company operates through two segments: Sample Management Solutions, offering SRS and Core Products such as automated stores, cryogenic systems, sample tubes, consumables, instruments, and thawing devices, which generate majority of its revenue; and Multiomics, which provides genomic analysis services. The company operates in United States, China, United Kingdom, rest of Europe, and others, with majority of its revenue in the United States.


Founded

1978

HQ

United States of America
Employees

3K+

Website

azenta.com

Financials

LTM Revenue $600M

LTM EBITDA $71.2M

EV

$1.5B

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Azenta Financials

As of December 2025, Azenta reported last 12-month revenue of $600M and EBITDA of $71.2M.

In the same period, Azenta generated $278M in LTM gross profit and $26.7M in net income.

See Azenta valuation multiples based on analyst estimates

Azenta P&L

In the most recent fiscal year, Azenta reported revenue of $594M and EBITDA of $39.5M.

Azenta expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Azenta valuation multiples based on analyst estimates
LTM NTM Last FY FY 2026 FY 2027 FY 2028
Revenue $600M XXX $594M XXX XXX XXX
Gross Profit $278M XXX $270M XXX XXX XXX
Gross Margin 46% XXX 46% XXX XXX XXX
EBITDA $71.2M XXX $39.5M XXX XXX XXX
EBITDA Margin 12% XXX 7% XXX XXX XXX
EBIT $20.6M XXX -$21.7M XXX XXX XXX
EBIT Margin 3% XXX -4% XXX XXX XXX
Net Profit $26.7M XXX -$55.8M XXX XXX XXX
Net Margin 4% XXX -9% XXX XXX XXX
Net Debt XXX XXX n/a XXX XXX XXX

Financial data powered by Morningstar, Inc.

Azenta Stock Performance

Azenta has current market cap of $1.8B, and EV of $1.5B.

Market Cap Evolution

Azenta Stock Data

As of January 19, 2026, Azenta's stock price is $40.

See Azenta trading valuation data
EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$1.5B $1.8B XXX XXX XXX XXX $0.58

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Azenta Valuation Multiples

Azenta's trades at 2.6x EV/Revenue multiple, and 30.2x EV/EBITDA.

See valuation multiples for Azenta and 15K+ public comps

Azenta Financial Valuation Multiples

As of January 19, 2026, Azenta has market cap of $1.8B and EV of $1.5B.

Equity research analysts estimate Azenta's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

Azenta has a P/E ratio of 69.0x.

LTM NTM Last FY FY 2026 FY 2027 FY 2028
Market cap (current) $1.8B XXX $1.8B XXX XXX XXX
EV (current) $1.5B XXX $1.5B XXX XXX XXX
EV/Revenue 2.6x XXX 2.6x XXX XXX XXX
EV/EBITDA 21.8x XXX 30.2x XXX XXX XXX
EV/EBIT 75.2x XXX -199.3x XXX XXX XXX
EV/Gross Profit 5.6x XXX n/a XXX XXX XXX
P/E 69.0x XXX -56.1x XXX XXX XXX
EV/FCF 39.5x XXX 39.5x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Azenta Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Azenta Margins & Growth Rates

Azenta's last 12 month revenue growth is 4%

Azenta's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.

Azenta's rule of 40 is 8% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Azenta's rule of X is 23% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Azenta and other 15K+ public comps

Azenta Operational Valuation Multiples

LTM NTM Last FY FY 2026 FY 2027 FY 2028
Revenue Growth 4% XXX 5% XXX XXX XXX
EBITDA Margin 12% XXX 9% XXX XXX XXX
EBITDA Growth 28% XXX 98% XXX XXX XXX
Rule of 40 8% XXX 13% XXX XXX XXX
Bessemer Rule of X XXX XXX 23% XXX XXX XXX
Revenue per Employee XXX XXX $0.2M XXX XXX XXX
Opex per Employee XXX XXX $0.1M XXX XXX XXX
S&M Expenses to Revenue XXX XXX n/a XXX XXX XXX
G&A Expenses to Revenue XXX XXX n/a XXX XXX XXX
R&D Expenses to Revenue XXX XXX 5% XXX XXX XXX
Opex to Revenue XXX XXX 49% XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Azenta Public Comps

See public comps and valuation multiples for Laboratory Services and Genomics & Personalized Medicine comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Australian Clinical Labs XXX XXX XXX XXX XXX XXX
ALS XXX XXX XXX XXX XXX XXX
Healius XXX XXX XXX XXX XXX XXX
Integral Diagnostics XXX XXX XXX XXX XXX XXX
Sonic Healthcare XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Azenta M&A and Investment Activity

Azenta acquired  XXX companies to date.

Last acquisition by Azenta was  XXXXXXXX, XXXXX XXXXX XXXXXX . Azenta acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Azenta

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 65K+ M&A deals.

Start Free Trial

About Azenta

When was Azenta founded? Azenta was founded in 1978.
Where is Azenta headquartered? Azenta is headquartered in United States of America.
How many employees does Azenta have? As of today, Azenta has 3K+ employees.
Who is the CEO of Azenta? Azenta's CEO is Mr. John P. Marotta.
Is Azenta publicy listed? Yes, Azenta is a public company listed on NAS.
What is the stock symbol of Azenta? Azenta trades under AZTA ticker.
When did Azenta go public? Azenta went public in 1995.
Who are competitors of Azenta? Similar companies to Azenta include e.g. Australian Clinical Labs, ALS, Healius, Integral Diagnostics.
What is the current market cap of Azenta? Azenta's current market cap is $1.8B
What is the current revenue of Azenta? Azenta's last 12 months revenue is $600M.
What is the current revenue growth of Azenta? Azenta revenue growth (NTM/LTM) is 4%.
What is the current EV/Revenue multiple of Azenta? Current revenue multiple of Azenta is 2.6x.
Is Azenta profitable? Yes, Azenta is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of Azenta? Azenta's last 12 months EBITDA is $71.2M.
What is Azenta's EBITDA margin? Azenta's last 12 months EBITDA margin is 12%.
What is the current EV/EBITDA multiple of Azenta? Current EBITDA multiple of Azenta is 21.8x.
What is the current FCF of Azenta? Azenta's last 12 months FCF is $39.2M.
What is Azenta's FCF margin? Azenta's last 12 months FCF margin is 7%.
What is the current EV/FCF multiple of Azenta? Current FCF multiple of Azenta is 39.5x.

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.